Euronext (EPA:ENX) received a €65.00 ($75.58) price objective from equities research analysts at JPMorgan Chase & Co. in a research note issued on Tuesday. The firm presently has a “buy” rating on the stock. JPMorgan Chase & Co.’s target price would suggest a potential upside of 7.53% from the company’s previous close.

A number of other research analysts also recently commented on ENX. Barclays set a €57.00 ($66.28) price objective on shares of Euronext and gave the company a “neutral” rating in a research report on Thursday, June 21st. HSBC set a €56.00 ($65.12) price objective on shares of Euronext and gave the company a “neutral” rating in a research report on Wednesday, July 18th. Finally, UBS Group set a €49.00 ($56.98) price objective on shares of Euronext and gave the company a “sell” rating in a research report on Tuesday, August 14th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of €58.00 ($67.44).

Shares of ENX opened at €60.45 ($70.29) on Tuesday. Euronext has a 52 week low of €39.37 ($45.78) and a 52 week high of €61.35 ($71.34).

Euronext Company Profile

Euronext N.V., together with its subsidiaries, operates securities and derivatives exchanges in Continental Europe. The company offers a range of exchange and corporate services, including security listings, cash and derivatives trading, and market data dissemination. It also provides listing venues; and cash trading services, which include the provision of various marketplaces for investors, broker-dealers, and other market participants to directly buy and sell cash equities, fixed income securities, and exchange traded products.

See Also: Put Option

Analyst Recommendations for Euronext (EPA:ENX)

Receive News & Ratings for Euronext Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euronext and related companies with MarketBeat.com's FREE daily email newsletter.